查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847720

血液處理設備及耗材市場（依產品類型、技術、應用、最終用戶及通路分類）－2025-2032年全球預測

Blood Processing Devices & Consumables Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液處理設備和耗材市場規模將達到 1,166 億美元，複合年成長率為 10.88%。

主要市場統計數據
基準年 2024 510.2億美元
預計年份：2025年 566.4億美元
預測年份：2032年 1166億美元
複合年成長率 (%) 10.88%

建構一個全面的框架，闡述影響血液處理設備和耗材未來應用的臨床、技術、監管和營運動態。

血液處理設備和耗材領域正經歷臨床需求、技術創新和日益嚴格的監管要求三者交匯的演變。醫療機構、實驗室主任和採購團隊面臨著不斷變化的環境，設備性能、耗材品質和工作流程整合決定臨床可靠性和營運效率。本執行摘要概述了對血液採集、分離、檢測和儲存環節的決策者而言最重要的促進因素和實際影響。

在臨床環境中，需求訊號日益受到平衡吞吐量和安全性的需求所驅動。自動化處理和病原體去活化技術的創新旨在降低變異性並提高安全性，而耗材設計的進步則旨在簡化操作並延長保存期限。同時，監管審查和合規框架正在推動製造商和最終用戶之間更緊密的合作，重點關注可追溯性、驗證通訊協定和上市後監測。這些因素的匯聚促使各組織在採購和採用技術時優先考慮互通性、供應鏈韌性和生命週期支援。

本文所採用的組裝旨在闡明技術能力、以使用者為中心的設計以及政策促進因素如何塑造一個更加一體化、以品質為導向的市場，從而為後續分析奠定基礎。此外，它還提供了一個視角，用於審視市場區隔、區域動態、關稅影響和競爭定位，並為臨床、實驗室和研究領域的相關人員提供切實可行的觀點。

自動化、病原體緩解創新和整合生命週期支援如何重新定義臨床血液處理中的採購優先事項和營運模式

隨著自動化技術的成熟、病原體控制技術的進步以及數據主導的品質保證日益融入工作流程，血液處理生態系統正在經歷一場變革。自動化處理平台正從實驗性部署走向高通量處理中心的主流應用，改變了手動操作的角色，並重新定義了人員配置模式。隨著這些平台規模的擴大，人們的關注點正從服務點效能轉向系統互通性和全生命週期總擁有成本，從而推動了新的採購標準和供應商服務期望的訂定。

同時，病原體去活化系統和先進診斷技術的進步提高了安全性標準，同時也刺激了對相容耗材和檢驗的處理通訊協定的需求。這些技術進步與改進的儲存和運輸設備相輔相成，延長了保存期限並提高了溫度控制精度，從而拓寬了血站和醫院的物流選擇。所有這些因素累積促成了一個市場趨勢：模組化、適應性強的解決方案更受青睞，能夠整合到不同的臨床流程中。

在營運方面，終端用戶重視可追溯性、即時品質指標和簡化的使用者介面，以減輕培訓負擔並減少操作錯誤。分銷模式也不斷演變：對於複雜的設備，直銷關係依然存在；而對於標準化耗材和替換零件，經銷商和電子商務通路的重要性日益凸顯。這些轉變正在創造一個更互聯、以效率為導向的環境，這將使那些能夠將強大的工程技術、快速反應的支援和檢驗的臨床工作流程相結合的製造商獲得豐厚的回報。

關稅主導的供應鏈重組和採購韌性：透過策略重組採購、在地化生產和多元化高效供應商

美國近期加徵的關稅為製造商、經銷商和終端用戶帶來了新的考量，不僅影響直接成本，也影響供應鏈結構、籌資策略和供應商選擇。關稅帶來的價格壓力促使企業重新評估零件採購，盡可能實現在地化生產，並實現供應商多元化以降低風險敞口。雖然這些策略調整短期內會增加複雜性，但從長遠來看，它們也會加速對本地製造和合格替代供應管道的投資。

對於醫療設備和耗材製造商而言，關稅正在影響其最終組裝的選擇以及如何建立供應商合約以在確保合規性的同時保障淨利率。終端使用者和採購團隊正在透過擴大供應商資格認證範圍、納入更多供應商以及協商能夠應對前置作業時間延長的服務和保固條款來應對這項挑戰。在調整採購策略的同時，企業也更加重視庫存管理，包括採取緩衝庫存措施和準確的需求預測，以降低關稅導致的供應波動對業務中斷的風險。

監管管道和檢驗要求可能會使快速更換供應商變得複雜，尤其對於抗凝血劑、過濾器和血袋等關鍵耗材而言。因此，各組織需要在成本控制和檢驗流程的連續性之間尋求平衡。總而言之，關稅環境正促使整個價值鏈朝著更謹慎、注重韌性的方向發展，強調供應商冗餘、在地化能力和嚴格的變更控制機制。

將產品類別、自動化模式、臨床應用、使用者畫像和分銷管道與策略需求連結起來的詳細細分分析

細緻的細分觀點揭示了價值與風險在產品類型、技術、應用、最終用戶和分銷管道中的交匯點。耗材包括抗凝血劑和添加劑、血袋和輸血器、過濾器和檢測套組，而設備則包括血漿分離機、離心機、病原體去活化系統和儲存設備。每類產品都有不同的監管管道、耗材生命週期要求和使用者培訓要求，這些都會影響產品的普及速度和服務模式。

技術細分區分了自動化處理和手動處理，凸顯了全自動系統在高效能環境中的重要性日益成長，以及半自動化系統在資源受限環境中的重要性日益成長。這種技術上的二分法導致不同臨床環境的支出模式和整合需求存在差異：自動化解決方案著重於軟體整合、資料管理和供應商支援的維護，而手動流程則高度依賴耗材標準化和使用者能力。

血液採集、成分分離、診斷檢測、病原體去除以及儲存/運輸等不同應用場景下的差異，導致了性能指標和檢驗查核點的多樣性。包括血庫、診斷實驗室、醫院診所和研究機構在內的終端用戶，其優先事項也各不相同。在血庫中，供應的連續性和合規性至關重要；在實驗室中，診斷準確性和通量是選擇指南；在醫院中，臨床適用性和床邊人體工學設計至關重要；而在研究環境中，靈活性和實驗控制是重中之重。分銷管道涵蓋了從複雜設備的直接銷售到分銷商和耗材的電子商務，這些管道影響著前置作業時間、服務模式和價格透明度。這些細分洞察凸顯了產品開發、商業策略和售後支援必須與每個使用者群體和技術類別的具體需求相符的重要性。

對美洲、中東和非洲以及亞太地區的監管複雜性、基礎設施多樣性和分銷重要性進行比較評估

美洲、中東和非洲以及亞太地區的區域動態差異顯著，不同的監管、報銷和基礎設施環境會影響招募管道和供應商策略。在美洲，採購和臨床網路通常強調規模和整合，傾向於採用整合解決方案和服務包，以降低大型中心的營運複雜性。該地區的法規結構支援既定的檢驗流程，物流網路通常也便於集中配送設備和耗材。

中東和非洲的醫療保健體系千差萬別，部分地區的市場准入受到嚴格的監管標準約束，而另一些地區則面臨基礎設施不足的限制。這種多樣性為產品設計提供了機會，使其能夠適應資源豐富和資源匱乏的環境。在該地區運作的相關人員經常需要應對跨境監管協調、不同的報銷規則以及維持臨床連續性所需的強大售後服務。

亞太地區既擁有成熟市場（具備先進的檢測能力），也擁有快速發展的新興市場（正在拓展血液服務）。本地製造業投資和貿易政策影響供應鏈決策，而終端用戶往往尋求既經濟高效又不影響安全性的解決方案。在整個全部區域，與本地經銷商夥伴關係以及建立策略性的本地服務網路對於確保運作和符合監管要求至關重要。這些區域性洞察共同指導供應商如何調整打入市場策略、支援模式和產品組合，以適應當地的臨床和營運實際情況。

競爭動態和策略定位強調臨床檢驗、整合服務網路和有針對性的夥伴關係關係，以拓展產品組合。

競爭動態的核心在於成熟的醫療設備製造商、專業耗材製造商以及提供新型自動化或診斷技術的參與企業企業。領先企業透過結合檢驗的臨床表現、完善的服務體係以及提供可互通的解決方案的能力來脫穎而出，這些解決方案能夠相容於不同的實驗室資訊系統和醫院工作流程。對於那些希望夥伴關係其在器械和耗材領域產品組合，同時彌補病原體去活化、自動化和低溫運輸解決方案方面能力缺口的企業而言，策略合作和有針對性的收購是常見的策略。

成熟的公司通常利用全球服務網路和延長保固期來支援大型血站和醫院系統採用其產品，而創新型挑戰者則在模組化、更低的初始成本和軟體驅動的工作流程效率方面展開競爭。擁有直銷團隊負責複雜設備部署的公司通常會簽訂長期服務協議，而那些利用經銷商關係和電子商務管道的公司則強調可擴展性和耗材的快速補充。

市場參與企業正日益增加對證據產生的投入，包括臨床檢驗和真實世界表現測試，以支持採購決策和報銷談判。這種對臨床可靠性的投入，加上可證明的總體擁有成本優勢和強大的客戶支持，對於贏得機構合約以及與臨床、實驗室和研究終端用戶簽訂長期特許權使用費至關重要。

領導者需採取切實可行的營運和商業措施，以平衡創新、供應鏈韌性和以客戶為中心的全生命週期支援。

產業領導者應優先考慮協作方式，在創新、供應鏈韌性和以使用者為中心的設計之間取得平衡。製造商必須投資於模組化自動化平台，這些平台可根據不同的吞吐量需求進行配置，同時確保與各種耗材相容，從而減少客戶切換過程中的摩擦。同時，對完善的售後服務、遠距離診斷和軟體更新進行投資，可以保障運作並維持長期的客戶關係。

供應鏈策略應強調合格的多供應商採購、區域組裝能力以及能夠降低貿易中斷風險的庫存管理實務。營運團隊應建立規範的變更管理管道，以加快替代供應商的資格認證，同時確保不影響驗證要求。商務團隊應採用反映全生命週期成本（而不僅僅是單位成本）的合約模式，並將獎勵與服務績效、耗材供應和臨床結果相結合。

最後，領導者應積極與監管機構、標準組織和臨床相關人員合作，為新技術（特別是病原體去活化和高度自動化系統）制定切實可行的驗證框架。投資於可操作證據的產生、臨床醫生培訓項目和可互通的數據標準，將加速新技術的應用，並降低醫院、血庫和實驗室採購決策的風險。

此方法框架結合了關鍵相關人員的洞察、監管環境分析和供應商概況，以產生可操作且檢驗的市場情報。

本研究整合了一手和二手資料，旨在建立基於實證的血液處理設備和耗材市場格局圖景。一手資料包括對臨床醫生、實驗室主任、採購專業人員和技術負責人的結構化訪談，並輔以設備和耗材的生命週期文件、臨床檢驗報告和監管申報文件。二手資料包括同行評審的臨床文獻、技術標準和政策出版刊物，這些資料為產品性能聲明和市場推廣促進因素提供了背景資訊。

我們的分析方法結合了相關人員訪談的質性主題編碼和產品及供應商對比分析，以識別設計、可用性和服務模式方面的差異化因素。我們將監管管道和檢驗要求與產品類別進行匹配，以識別推廣障礙。我們的供應鏈分析考慮了組件採購、生產佈局和分銷模式，而風險評估則評估了關稅、前置作業時間波動和單一來源依賴性的影響。在整個方法論過程中，我們專注於確保其穩健性，並對採購、調查方法和資料來源進行三角驗證，以揭示對採購、調查方法、資料來源和商業策略的實際意義。

一項強調檢驗的績效、靈活的服務模式和穩健的採購的綜合策略要務，旨在確保長期的臨床和商業性成功。

整體而言，成功的新參與企業和現有企業必須具備以下條件：擁有檢驗的臨床記錄、適應性強、以服務為導向的經營模式以及穩健的供應鏈。自動化和病原體去活化的技術進步能夠帶來顯著的臨床和營運效益，但其應用取決於可驗證的互通性、簡化的檢驗管道以及強大的售後支援。耗材的品質和相容性仍然是保障安全性和工作流程效率的基礎，因此設備製造商和耗材供應商之間的密切合作至關重要。

區域和監管差異要求採取獨特的市場進入策略，重點在於本地服務能力和證據生成，以支持採購決策。不斷變化的關稅環境和貿易政策加大了採購多元化的壓力，並促使企業盡可能投資於本地製造和組裝。最終，市場將獎勵那些能夠提供可預測結果、降低臨床團隊工作複雜性並提供透明的全生命週期價值的供應商。優先考慮這些因素的相關人員將能夠在應對經濟和政策逆風的同時，滿足不斷變化的臨床需求。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 提高血小板和血漿安全病原體減少技術的應用
  • 將人工智慧和預測分析整合到血液處理工作流程中
  • 開發封閉式血液採集和處理試劑套件，以最大限度降低污染風險
  • 具備高通量多組分採集能力的先進分析系統快速發展
  • 增加血漿分餾用一次性耗材，以提高規模化生產能力並減少交叉污染
  • 擴大移動式和照護現場血液分離裝置的規模，以應對偏遠地區和緊急情況
  • 一種相容於多種抗凝血劑和無抗凝血劑方法的通用血液處理平台的出現
  • 監管機構強調標準化安全通訊協定，並鼓勵採用自動血液離心機。
  • 增加對基於微流體的診斷投資，以實現快速現場血液成分分析和品質保證

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的血液處理設備和耗材市場

  • 消耗品
    • 抗凝血劑和添加劑
    • 血袋和套裝
    • 篩選
    • 檢測套組
  • 裝置
    • 血液分離機
    • 離心機
    • 病原體減少系統
    • 儲存裝置

9. 按技術分類的血液處理設備及耗材市場

  • 自動處理
    • 全自動系統
    • 半自動系統
  • 手動處理

第10章 依應用分類的血液處理設備及耗材市場

  • 血液收集
  • 組分分離
  • 診斷測試
  • 病原體清除
  • 倉儲和運輸

第11章 依最終用戶分類的血液處理設備和耗材市場

  • 血庫
  • 診斷實驗室
  • 醫院和診所
  • 研究所

第12章：血液處理設備及耗材市場（依通路分類）

  • 直銷
  • 經銷商
  • 電子商務

第13章：血液處理設備及耗材市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血液處理設備及耗材市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國血液處理設備及耗材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Haemonetics Corporation
    • Terumo Corporation
    • Pall Corporation
    • Fresenius Kabi AG
    • Grifols, SA
    • Octapharma AG
    • Macopharma SA
    • GE Healthcare Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • Miltenyi BIoTec GmbH
Product Code: MRR-AB49FC1AB774

The Blood Processing Devices & Consumables Market is projected to grow by USD 116.60 billion at a CAGR of 10.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 51.02 billion
Estimated Year [2025] USD 56.64 billion
Forecast Year [2032] USD 116.60 billion
CAGR (%) 10.88%

Comprehensive framing of clinical, technological, regulatory, and operational dynamics shaping the future adoption of blood processing devices and consumables

The landscape for blood processing devices and consumables is evolving at the intersection of clinical need, technological innovation, and tightening regulatory expectations. Providers, laboratory directors, and procurement teams are navigating a shifting environment in which device performance, consumable quality, and workflow integration determine clinical reliability and operational efficiency. This executive summary synthesizes the thematic drivers and practical implications that matter most to decision-makers managing blood collection, separation, testing, and storage pathways.

Across clinical settings, demand signals are increasingly shaped by the need to balance throughput with safety. Innovations in automated processing and pathogen reduction aim to reduce variability and enhance safety, while consumable design advances seek to streamline handling and extend shelf life. At the same time, regulatory scrutiny and compliance frameworks are prompting closer alignment between manufacturers and end users, focusing on traceability, validation protocols, and postmarket surveillance. The convergence of these forces is leading organizations to prioritize interoperability, supply chain resilience, and lifecycle support during procurement and technology adoption.

This introduction frames the subsequent analysis by highlighting how technical performance, user-centric design, and policy drivers are creating a more integrated, quality-focused market. It also establishes the lens through which we examine segmentation, regional dynamics, tariff effects, and competitive positioning to surface actionable perspectives for stakeholders across clinical, laboratory, and research environments.

How automation, pathogen mitigation innovations, and integrated lifecycle support are redefining procurement priorities and operational models across clinical blood processing

The blood processing ecosystem is undergoing transformative shifts as automation matures, pathogen mitigation technologies advance, and data-driven quality assurance becomes increasingly embedded in workflows. Automated processing platforms are moving from experimental adoption to mainstream deployment in high-volume centers, which is altering the role of manual methods and redefining staffing models. As these platforms scale, attention shifts from single-function performance to system interoperability and lifecycle total cost of ownership, prompting new procurement criteria and vendor-service expectations.

Simultaneously, pathogen reduction systems and enhanced diagnostics are raising the bar for safety while stimulating demand for compatible consumables and validated processing protocols. These technological strides are complemented by improvements in storage and transport equipment that enable extended preservation windows and better temperature control, thereby expanding logistical options for blood centers and hospitals. The cumulative effect is a market that favors modular, adaptable solutions capable of integrating into diverse clinical pathways.

Operationally, end users are placing a premium on traceability, real-time quality metrics, and simplified user interfaces to lower training burdens and reduce handling errors. Distribution models are also evolving: direct sales relationships persist for complex instruments while distributors and e-commerce channels grow in importance for standardized consumables and replacement parts. Together, these shifts create a more connected, efficiency-oriented environment that rewards manufacturers who combine robust engineering with responsive support and validated clinical workflows.

Tariff-driven supply chain realignment and procurement resilience strategies that reshape sourcing, production localization, and validated supplier diversification

Recent tariff actions in the United States have introduced new considerations for manufacturers, distributors, and end users that extend beyond immediate cost implications to influence supply chain architecture, sourcing strategies, and vendor selection. Tariff-related pricing pressures incentivize companies to reassess component sourcing, regionalize production where feasible, and pursue supplier diversification to mitigate exposure. These strategic shifts can increase near-term complexity but also accelerate longer-term investments in local manufacturing and qualified alternative supply streams.

For manufacturers of both devices and consumables, tariffs influence decisions about where to base final assembly and how to structure supplier contracts to preserve margin while maintaining regulatory compliance. End users and procurement teams respond by expanding qualification processes to include additional suppliers and by negotiating service and warranty terms that account for longer lead times. Alongside procurement adjustments, there is a renewed emphasis on inventory management practices, including buffer stock policies and demand forecasting accuracy, to reduce risk of operational disruption during tariff-induced supply volatility.

Regulatory pathways and validation requirements can complicate rapid source substitutions, especially for critical consumables such as anticoagulants, filters, and blood bags. Consequently, organizations are balancing the trade-offs between cost containment and continuity of validated processes. In summary, the tariff environment is prompting a more deliberate, resilience-focused orientation across the value chain that emphasizes supplier redundancy, regional capacity, and rigorous change control mechanisms.

Deep segmentation analysis linking product classes, automation paradigms, clinical applications, user profiles, and distribution pathways to strategic imperatives

A nuanced segmentation view reveals where value and risk converge across product types, technologies, applications, end users, and distribution channels. Product-level differentiation separates consumables from devices, with consumables encompassing anticoagulants and additives, blood bags and sets, filters, and test kits, while devices cover apheresis machines, centrifuges, pathogen reduction systems, and storage equipment. Each product class carries distinct regulatory pathways, consumable lifecycle demands, and user training requirements that influence adoption cadence and service models.

Technology segmentation distinguishes automated processing from manual processing, highlighting the growing relevance of fully automated systems and semi-automated systems in high-throughput and resource-constrained settings respectively. This technological bifurcation drives varied spending patterns and integration needs across clinical environments, with automated solutions emphasizing software integration, data management, and vendor-supported maintenance, while manual processes depend more heavily on consumable standardization and user competency.

Application-based differences, spanning blood collection, component separation, diagnostic testing, pathogen reduction, and storage and transportation, create divergent performance metrics and validation checkpoints. End users such as blood banks, diagnostic laboratories, hospitals and clinics, and research institutes impose different priorities: supply continuity and regulatory compliance dominate in blood banks, diagnostic precision and throughput guide laboratory choices, clinical compatibility and bedside ergonomics matter in hospitals, and flexibility and experimental control are paramount in research settings. Distribution channels range from direct sales for complex instrumentation to distributors and e-commerce for consumables, shaping lead times, service models, and price transparency. These segmentation insights underscore the importance of aligning product development, commercial strategy, and post-sale support with the specific needs of each user cohort and technology class.

Comparative regional assessment of regulatory complexity, infrastructure variability, and distribution imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics vary meaningfully across the Americas, Europe Middle East and Africa, and Asia Pacific, each presenting distinct regulatory, reimbursement, and infrastructure landscapes that influence adoption pathways and supplier strategies. In the Americas, procurement and clinical networks often emphasize scale and consolidation, which favors integrated solutions and service bundles that reduce operational complexity in high-volume centers. Regulatory frameworks in this region support established validation processes, and logistic networks generally facilitate centralized distribution for both devices and consumables.

Europe Middle East and Africa comprises a heterogeneous set of health systems where market access is influenced by stringent regulatory standards in some jurisdictions and constrained infrastructure in others. This diversity creates opportunities for adaptable product designs that can be configured for both resource-rich and resource-limited settings. Stakeholders operating in this region frequently must navigate cross-border regulatory harmonization, varied reimbursement rules, and the need for strong after-sales service to maintain clinical continuity.

Asia Pacific includes mature markets with advanced laboratory capabilities alongside rapidly developing healthcare systems that are scaling blood services. Local manufacturing investments and trade policies influence supply chain decisions, and end users often seek cost-effective solutions that do not compromise safety. Across the region, partnerships with regional distributors and strategic local service networks are essential to ensure uptime and regulatory compliance. Collectively, these regional insights inform how vendors should tailor market entry strategies, support models, and product configurations to align with local clinical and operational realities.

Competitive dynamics and strategic positioning that emphasize clinical validation, integrated service networks, and targeted partnerships to strengthen portfolio breadth

Competitive dynamics center on a mix of established medical device manufacturers, specialist consumable producers, and emerging technology entrants that offer novel automation or diagnostic capabilities. Leading players differentiate through a combination of validated clinical performance, comprehensive service ecosystems, and the ability to provide interoperable solutions that fit into diverse laboratory information systems and hospital workflows. Strategic partnerships and targeted acquisitions have been common tactics for firms seeking to broaden portfolios across both devices and consumables while closing capability gaps in pathogen reduction, automation, and cold chain solutions.

Mature companies typically leverage global service networks and extended warranties to support adoption in large-scale blood centers and hospital systems, whereas innovative challengers compete on modularity, lower upfront cost, and software-enabled workflow efficiencies. Distribution approaches also create competitive separation: organizations that maintain direct sales teams for complex instrument placements often embed long-term service agreements, while those that capitalize on distributor relationships or e-commerce channels emphasize scalability and rapid replenishment for consumables.

Market participants are increasingly investing in evidence generation, including clinical validations and real-world performance studies, to support procurement decisions and reimbursement discussions. This investment in clinical credibility, combined with demonstrable cost of ownership advantages and strong customer support, is central to winning both institutional contracts and long-term loyalty across clinical, laboratory, and research end users.

Actionable operational and commercial imperatives for leaders to balance innovation, supply chain resilience, and customer-centric lifecycle support

Industry leaders should prioritize a coordinated approach that balances innovation with supply chain resilience and user-centered design. Manufacturers must invest in modular automation platforms that can be configured across different throughput profiles, while ensuring compatibility with a broad range of consumables to reduce switching friction for customers. Parallel investments in robust post-sale service, remote diagnostics, and software updates will protect uptime and maintain long-term customer relationships.

Supply chain strategies should focus on qualified multi-sourcing, regional assembly capabilities, and inventory policies that reduce exposure to trade disruptions. Operational teams ought to formalize change control pathways that accelerate qualification of alternate suppliers without compromising validation requirements. Commercial teams should adapt contracting approaches to reflect total lifecycle costs rather than unit pricing alone, aligning incentives for service performance, consumable availability, and clinical outcomes.

Finally, leaders should engage proactively with regulators, standards bodies, and clinical stakeholders to shape pragmatic validation frameworks for new technologies, particularly pathogen reduction and highly automated systems. Investing in pragmatic evidence generation, clinician training programs, and interoperable data standards will accelerate adoption and de-risk procurement decisions for hospitals, blood banks, and laboratories.

Methodological framework blending primary stakeholder insights, regulatory mapping, and supplier profiling to produce pragmatic, verifiable market intelligence

This research synthesizes primary and secondary intelligence to develop an evidence-based view of the blood processing devices and consumables landscape. Primary inputs include structured interviews with clinicians, laboratory directors, procurement specialists, and technology leaders, complemented by device and consumable lifecycle documentation, clinical validation reports, and regulatory filings. Secondary inputs include peer-reviewed clinical literature, technical standards, and policy publications that contextualize product performance claims and adoption drivers.

The analytical approach combines qualitative thematic coding of stakeholder interviews with comparative product and supplier profiling to identify differentiators in design, usability, and service models. Regulatory pathways and validation requirements were mapped to product classes to clarify adoption barriers. Supply chain analysis considered component sourcing, manufacturing footprints, and distribution models, while risk assessments evaluated tariff impacts, lead time variability, and single-source dependencies. Throughout the methodology, emphasis was placed on triangulating multiple data sources to ensure robustness and to surface practical implications for procurement, R&D, and commercial strategy.

Synthesis of strategic imperatives emphasizing validated performance, adaptable service models, and resilient sourcing to secure long-term clinical and commercial success

The overarching conclusion is that successful entrants and incumbents will be those who combine validated clinical performance with adaptable, service-oriented business models and resilient supply chains. Technological advances in automation and pathogen reduction offer meaningful clinical and operational benefits, but their adoption depends on demonstrable interoperability, streamlined validation pathways, and strong post-sale support. Consumable quality and compatibility remain foundational to maintaining safety and workflow efficiency, making close collaboration between device manufacturers and consumable suppliers essential.

Regional and regulatory differences require tailored go-to-market approaches, with an emphasis on local service capabilities and evidence generation to support procurement decisions. Tariff environments and trade policy shifts add pressure to diversify sourcing and invest in regional manufacturing or assembly where feasible. Ultimately, the market rewards providers who deliver predictable outcomes, reduce complexity for clinical teams, and provide transparent total lifecycle value. Stakeholders that prioritize these imperatives will be better positioned to meet evolving clinical demands while navigating economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of pathogen reduction technologies for platelet and plasma safety
  • 5.2. Integration of artificial intelligence and predictive analytics in blood processing workflows
  • 5.3. Development of closed-system blood collection and processing kits to minimize contamination risk
  • 5.4. Surge in advanced apheresis systems offering high-throughput multi-component collection capabilities
  • 5.5. Growth in single-use consumables for plasma fractionation to enhance scalability and reduce cross-contamination
  • 5.6. Expansion of mobile and point-of-care blood separation units for remote and emergency settings
  • 5.7. Emergence of universal blood processing platforms compatible with multiple anticoagulants and anticoagulant-free methods
  • 5.8. Regulatory emphasis on standardized safety protocols driving adoption of automated blood centrifugation devices
  • 5.9. Rising investment in microfluidic-based diagnostics for rapid on-site blood component analysis and quality assurance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Devices & Consumables Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Anticoagulants And Additives
    • 8.1.2. Blood Bags And Sets
    • 8.1.3. Filters
    • 8.1.4. Test Kits
  • 8.2. Devices
    • 8.2.1. Apheresis Machines
    • 8.2.2. Centrifuges
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Storage Equipment

9. Blood Processing Devices & Consumables Market, by Technology

  • 9.1. Automated Processing
    • 9.1.1. Fully Automated Systems
    • 9.1.2. Semi Automated Systems
  • 9.2. Manual Processing

10. Blood Processing Devices & Consumables Market, by Application

  • 10.1. Blood Collection
  • 10.2. Component Separation
  • 10.3. Diagnostic Testing
  • 10.4. Pathogen Reduction
  • 10.5. Storage And Transportation

11. Blood Processing Devices & Consumables Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals And Clinics
  • 11.4. Research Institutes

12. Blood Processing Devices & Consumables Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Blood Processing Devices & Consumables Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Processing Devices & Consumables Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Processing Devices & Consumables Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Haemonetics Corporation
    • 16.3.2. Terumo Corporation
    • 16.3.3. Pall Corporation
    • 16.3.4. Fresenius Kabi AG
    • 16.3.5. Grifols, S.A.
    • 16.3.6. Octapharma AG
    • 16.3.7. Macopharma S.A.
    • 16.3.8. GE Healthcare Technologies Inc.
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Miltenyi Biotec GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY,